Abrams david - direct investment history in Bellerophon therapeutics inc

Filed on 2015-12-03 by Abrams David SEC CIK 1630952 Form 4

Accession 0001179110-15-015705.txt Sec File: edgar/data/1630952/0001179110-15-015705-index.htm

2015-12-01 Abrams David (CIK 1630952) through Direct (Treasurer)

Invested in Bellerophon Therapeutics Inc bought 13116 shares at $0 remaining shares owned 13116

Common Stock Bellerophon Therapeutics Inc Blph Transaction code: A Grant, award, or other acquisition


Filed on 2015-03-16 by Abrams David SEC CIK 1630952 Form 4

Accession 0001179110-15-004964.txt Sec File: edgar/data/1630952/0001179110-15-004964-index.htm

2015-03-12 Abrams David (CIK 1630952) through Direct (Treasurer)

Invested in Bellerophon Therapeutics Inc bought 2564 shares at $0 remaining shares owned 2564

Stock Option Right To Buy Bellerophon Therapeutics Inc Blph exercise price 10.22 has valueitem expiration due date 2025-03-11 underlying security shares 2564 underlying security title Common Stock

f1 this option vested as to 25% of the underlying shares on march 13, 2015 (the "vesting commencement date") and vests as to an additional 25% of the underlying shares on each of the first, second and third anniversaries of the vesting commencement date.


Filed on 2015-02-19 by Abrams David SEC CIK 1630952 Form 4

Accession 0001104659-15-012179.txt Sec File: edgar/data/1630952/0001104659-15-012179-index.htm

2015-02-13 Abrams David (CIK 1630952) through Direct (Treasurer)

Invested in Bellerophon Therapeutics Inc bought 1995 shares at $0.00 remaining shares owned 1995

Stock Option Right To Buy Bellerophon Therapeutics Inc Blph exercise price 12.00 has valueitem expiration due date 2025-02-12 underlying security shares 1995 underlying security title Common Stock

f1 this option was granted on february 13, 2015. this option vests as to 25% of the underlying shares on each one year anniversary of the date of grant.